IRIDEX CORP — Director's Dealing 2014

Jan 7, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2014-01-04

Reporting Person: MOORE WILLIAM M (Director, Chairman and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-04	Performance Rights	$	A	50000	Acquired	2015-02-27	Common Stock (50000)	Direct

Footnotes

F1: The performance right represents a contingent right to receive up to 50,000 shares of IRIDEX common stock., The number of shares issuable pursuant to the performance right will be based upon the Company's average stock price performance or fair market value, as set forth within a Restricted Stock Unit Award Agreement between IRIDEX and the reporting person.